Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             268 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abbreviating Area Under the Curves Further: A Practical Approach To Monitoring Extended Pharmacokinetics With Neoral Sindhi, R
 1998
 30 4 p. 1197-1198
2 p.
 artikel
2 ABO Incompatible Kidney Transplantation on Triple Therapy Compared With Quadruple Therapy Aikawa, A
 1998
 30 4 p. 1337-1338
2 p.
 artikel
3 Accelerated Arteriosclerosis in Aortic Grafts: A Role for Activated Complement and IgM Antibody in Early Lesion Development Geerling, R.A
 1998
 30 4 p. 1017-1019
3 p.
 artikel
4 Accelerated Arteriosclerosis in Aortic Grafts: A Role for Cytokines in Progressive Intimal Lesion Development Geerling, R.A.
 1998
 30 4 p. 946-947
2 p.
 artikel
5 Activation of COL3A1 Promoter Activity by Cyclosporine 1 1 Supported by a grant from the Italian Ministry of Health to G. Gaslini Institute (Progetto Finalizzato M 1290059). Ginevri, F
 1998
 30 4 p. 955-956
2 p.
 artikel
6 Adjuvant Bone Marrow Infusion in Clinical Organ Transplant Recipients 1 1 Aided by project Grant #AI 40329 and DK 29961 from the National Institute of Health, Bethesda, Maryland. Rao, A.S
 1998
 30 4 p. 1367-1368
2 p.
 artikel
7 Analysis of B Cell Subsets Responsible for the Production of Anti-Donor Antibodies in Hamster-to-Rat Xenorejection Wakiyama, S.
 1998
 30 4 p. 1085-1086
2 p.
 artikel
8 An Effect of FTY720 on Acute Rejection in Canine Renal Transplantation Yuzawa, K.
 1998
 30 4 p. 1046-
1 p.
 artikel
9 An Experimental Model of Ischemia-Produced Transplant Arteriosclerosis Cole, O.J.
 1998
 30 4 p. 1020-
1 p.
 artikel
10 An Exploratory Analysis of Prognostic Factors for Patient Outcome During the First Year Following Renal Transplantation 1 1 This study was sponsored by Fujisawa GmbH, Munich. Richards, E
 1998
 30 4 p. 1386-1388
3 p.
 artikel
11 An Investigation Into the Effects of Cyclosporine and FK 506 on the Progress of Chronic Rejection in the Rat Aortic Model Cole, O.J
 1998
 30 4 p. 991-
1 p.
 artikel
12 A Novel In Vitro Model for Xenorejection and Immune Mechanisms Using Bioengineered Living Skin Equivalents 1 1 Supported, in part, by grants from the International Association of Fire Fighters Burn Foundation, the Orthopaedic Research and Education Foundation, the American Heart Association, the Plastic Surgery Educational Foundation, the Foundation of UMDNJ, and faculty practice grants from Robert Wood Johnson Medical School/Cooper Hospital/University Medical Center also the Physicians Committee for Responsible Medicine. Ramsamooj, R
 1998
 30 4 p. 1087-1088
2 p.
 artikel
13 Antibody Induction Therapy in Pancreas Transplantation Gruessner, R.W.G.
 1998
 30 4 p. 1556-1559
4 p.
 artikel
14 Anti-Human Class I α3 Domain-Specific Monoclonal Antibody Induces Programmed Cell Death in Murine Cells Expressing Human Class I MHC Transgenes Woodle, E.S
 1998
 30 4 p. 1059-1060
2 p.
 artikel
15 A Randomized Trial Comparing Anti-Interleukin-2 Receptor Antibody and Placebo for Immunosuppressive Therapy After OLT Langrehr, J.M
 1998
 30 4 p. 1445-1446
2 p.
 artikel
16 Area Under the Curve of Neoral and Chronic Use of Mycophenolate Mofetil Rial, M
 1998
 30 4 p. 1195-1196
2 p.
 artikel
17 ATGAM Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: Patient and Graft Survival, CD3 Subset, Infection, and Cost Analysis 1 1 This study was supported by a grant from Ortho-Biotech, Raritan, NJ. Kumar, M.S.A
 1998
 30 4 p. 1351-1352
2 p.
 artikel
18 ATG Induction Therapy and the Incidence of Bronchiolitis Obliterans After Lung Transplantation: Does It Make a Difference? Wiebe, K
 1998
 30 4 p. 1517-1518
2 p.
 artikel
19 Basic Science Aspects of Chronic Rejection: Induction of Protective Genes to Prevent Development of Transplant Arteriosclerosis Hancock, W.W.
 1998
 30 4 p. 1585-1589
5 p.
 artikel
20 Beneficial Immunosuppressive Effect of FTY720 Combined With Intrathymic Injection of Splenic Cells on Rat Pancreaticoduodenal Allograft Suzuki, K
 1998
 30 4 p. 1067-1068
2 p.
 artikel
21 Bioequivalence of a New Strength Tacrolimus Capsule Under Development Bekersky, I
 1998
 30 4 p. 1457-1459
3 p.
 artikel
22 Blockade of α4β1-Integrin–Fibronectin Adhesive Interactions Prevents Chronic Allograft Rejection in Sensitized Recipients 1 1 Supported by NIH Grant RO1AI23847. Coito, A.J
 1998
 30 4 p. 939-940
2 p.
 artikel
23 Blocking of Costimulatory Pathways Using Monoclonal Antibodies as a New Strategy to Prevent Transplant Rejection in a Non-Human Primate Model 1 1 Supported by the Human Capital Mobility program, grant CHGE-CT94-0071 and BIOMED II grant BMH4-CT96-0127. Ossevoort, M.A
 1998
 30 4 p. 1061-1062
2 p.
 artikel
24 Bone Marrow Augmentation in Renal Transplant Recipients Shapiro, R
 1998
 30 4 p. 1371-1374
4 p.
 artikel
25 Can Anti-HLA Antibody Analyses Postcardiac Transplantation Predict Acute Allograft Rejection and Survival? Bhat, G
 1998
 30 4 p. 1154-1157
4 p.
 artikel
26 Causes of Long-Term Renal Allograft Failure: No Chronic Rejection at Three Years Shen, G.K
 1998
 30 4 p. 1205-1206
2 p.
 artikel
27 CD95L Confers Immune Priviledge to Liver Grafts Which Are Spontaneously Accepted 1 1 Supported by the Deutsche Forschungsgemeinschaft, Fa 295/1-2. Fändrich, F
 1998
 30 4 p. 1057-1058
2 p.
 artikel
28 CD4-Targeted Therapy and CD28-B7 Costimulatory Blockage may Independently Induce Tolerance in Sensitized Allograft Recipients 1 1 Supported by USPHS grants A123847 and A134965. Kato, H
 1998
 30 4 p. 1063-1064
2 p.
 artikel
29 Cellular Surface Molecular and Cytokine Gene Expression in Rat Heart Allografts Under Optimal Doses of Cyclosporine and FK 506 Fujimura, T
 1998
 30 4 p. 1023-1026
4 p.
 artikel
30 Changes in T-Cell Subsets After Renal Transplantation in Nonimmunosuppressed Baboons Linley, W
 1998
 30 4 p. 1163-
1 p.
 artikel
31 Chronic Rejection Tilney, N.L
 1998
 30 4 p. 1590-1594
5 p.
 artikel
32 Clinical and Radiological Features of Two Cases of Tacrolimus-Related Posterior Leukoencephalopathy in Living Related Liver Transplantation Nakamura, M
 1998
 30 4 p. 1477-1478
2 p.
 artikel
33 Clinical Impact of Neoral in Heart Transplantation Aziz, T
 1998
 30 4 p. 1152-1153
2 p.
 artikel
34 Clinical Outcomes Associated With Conversion to Tacrolimus-Based Immunosuppression in Pediatric Cardiac Transplantation Walker, R.E.
 1998
 30 4 p. 1116-1117
2 p.
 artikel
35 Clinical Use and Bioavailability of Tacrolimus in Heart-Lung and Double Lung Transplant Recipients With Cystic Fibrosis Walker, S
 1998
 30 4 p. 1519-1520
2 p.
 artikel
36 Co-administration of Tacrolimus and Mycophenolate Mofetil in Cadaveric Renal Transplant Recipients 1 1 This study was sponsored by Fujisawa GmbH, Munich. Y. Vanrenterghem holds the Baxter Chair for Renal Transplantation at the KU Leuven. Vanrenterghem, Y
 1998
 30 4 p. 1290-1291
2 p.
 artikel
37 Combined Blockade of CD28/B7 and CD40/CD40L Costimulatory Pathways Prevents the Onset of Chronic Rejection 1 1 Supported by Grant #DK 29961 from the National Institutes of Health, Bethesda, Maryland. Subbotin, V
 1998
 30 4 p. 941-942
2 p.
 artikel
38 Combined Chronic Administration of Methotrexate and Cyclosporine A Following Cardiac Ongoing Rejection Forni, A.
 1998
 30 4 p. 1140-1142
3 p.
 artikel
39 Combined Effect of Rapamycin and Cyclosporine in the Prevention of Rat Corneal Allograft Rejection 1 1 Supported by a grant from the Eye Bank of Quebec and by Wyeth-Ayerst Research (Rouses Point, NY). Thompson, P
 1998
 30 4 p. 1033-1035
3 p.
 artikel
40 Combining FK 506 and Mycophenolate Mofetil for the Treatment of Acute Corticosteroid-Resistant Rejection Following Kidney Transplantation: A New Therapeutic Concept Carl, S.
 1998
 30 4 p. 1236-1237
2 p.
 artikel
41 Comparative Effects of Malononitriloamide Analogs of Leflunomide on Whole Blood Lymphocyte Stimulation in Humans, Rhesus Macaques, Cats, Dogs, and Rats Gregory, C.R.
 1998
 30 4 p. 1047-1048
2 p.
 artikel
42 Comparison of Neoral and Sandimmun Cyclosporines for De Novo Lung Transplantation in Cystic Fibrosis Patients Mikhail, G
 1998
 30 4 p. 1510-1511
2 p.
 artikel
43 Comparison of Quadruple Induction Including ATG or IL-2R Antibody With FK506-Based Therapy After Liver Transplantation Langrehr, J.M.
 1998
 30 4 p. 1439-1440
2 p.
 artikel
44 Comparison of Tacrolimus With Neoral as Primary Immunosuppression in Hepatitis C Patients After Liver Transplantation Zervos, X.A
 1998
 30 4 p. 1405-1406
2 p.
 artikel
45 Comparison of the Effect of FK 506 and α/β-T-Cell Antibody R73 on Transplant Vascular Sclerosis After Heterotopic Rat Heart Transplantation Silber, R.E
 1998
 30 4 p. 987-988
2 p.
 artikel
46 Construction of a Single-Chain Antibody Derived From 5H7, A Monoclonal Antibody Specific for a Death Signaling Domain of Human Class I Major Histocompatibility Complex 1 1 E.S.W. supported by NIH Grant# Po1-AI129531-07. Kulkarni, S
 1998
 30 4 p. 1081-
1 p.
 artikel
47 Contribution of the Inflammatory Response to Cardiac Allograft Rejection: Histopathologic Analysis of Serial Endomyocardial Biopsies Baan, C.C.
 1998
 30 4 p. 1104-1106
3 p.
 artikel
48 Controversies in Heart and Lung Transplantation Immunosuppression: Tacrolimus Versus Cyclosporine Kobashigawa, J.A.
 1998
 30 4 p. 1095-1097
3 p.
 artikel
49 Conversion From Cyclosporine to Tacrolimus in Renal Allograft Recipients With Chronic Graft Nephropathy: Preliminary Report Morris-Stiff, G.
 1998
 30 4 p. 1245-1246
2 p.
 artikel
50 Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis 1 1 This work was supported in part by La Fondation Notre-Dame. Busque, S
 1998
 30 4 p. 1247-1248
2 p.
 artikel
51 Conversion to Mycophenolate Mofetil for Chronic Progressive Deterioration of Renal Allograft Function: First Clinical Experiences in 44 Patients Fritsche, L
 1998
 30 4 p. 1190-1191
2 p.
 artikel
52 Conversion to Tacrolimus (FK506) From Cyclosporine After Orthotopic Lung Transplantation Lipson, D.A
 1998
 30 4 p. 1505-1507
3 p.
 artikel
53 Corticosteroid Cessation 1 Week Following Renal Transplantation Using Tacrolimus/Mycophenolate Mofetil Based Immunosuppression Grewal, H.P
 1998
 30 4 p. 1378-1379
2 p.
 artikel
54 Cost of Liver Transplantation Using Tacrolimus 1 1 This work was supported by a grant from Fujisawa, Canada. McAlister, V.C
 1998
 30 4 p. 1502-
1 p.
 artikel
55 Cyclosporine A-Associated Thrombotic Thrombocytopenic Purpura Following Lung Transplantation Roberts, P
 1998
 30 4 p. 1512-1513
2 p.
 artikel
56 Cyclosporine Monotherapy in Long-Term Pediatric Liver Transplant Recipients Martin, S.R
 1998
 30 4 p. 1424-1426
3 p.
 artikel
57 Cyclosporine Peak Levels Provide a Better Correlation With the Area-Under-The-Curve Than Trough Levels in Liver Transplant Patients Treated With Neoral 1 1 This study was supported by a grant of Novartis Pharma Canada Inc. Cantarovich, M
 1998
 30 4 p. 1462-1463
2 p.
 artikel
58 Cyclosporine-Related Hemolytic-Uremic Syndrome in Kidney Graft Recipients: Clinical and Histomorphologic Evaluation Bren, A.F
 1998
 30 4 p. 1201-1203
3 p.
 artikel
59 Cyclosporine to Tacrolimus: Effect on Hypertension and Lipid Profiles in Renal Allografts 1 1 This study was sponsored by a grant from Fujisawa USA, Inc., Deerfield, Illinois. Copley, J.B
 1998
 30 4 p. 1254-1256
3 p.
 artikel
60 Cyclosporine Versus Cyclosporine Microemulsion in Pediatric Liver Transplant Recipients Loss Jr., G.E
 1998
 30 4 p. 1435-1436
2 p.
 artikel
61 Cytolytic Induction Therapy in Heart and Lung Transplantation: The Protagonist Opinion Wahlers, Th.
 1998
 30 4 p. 1100-1103
4 p.
 artikel
62 Cytomegalovirus Infection and Prophylaxis in Renal Transplantation: Financial Considerations Wright Jr, F.H.
 1998
 30 4 p. 1318-1319
2 p.
 artikel
63 Decreasing Pancreatic Toxicity of Tacrolimus by Dosage Reduction Uchida, K
 1998
 30 4 p. 1276-1278
3 p.
 artikel
64 Demographic Considerations in Tacrolimus Pharmacokinetics Fitzsimmons, W.E
 1998
 30 4 p. 1359-1364
6 p.
 artikel
65 De Novo Cancer After Orthotopic Liver Transplantation Peyrègne, V
 1998
 30 4 p. 1484-1485
2 p.
 artikel
66 Depressed Expression of CD 28 Antigen on Lymphocytes in Long-Term Kidney Transplant Patients Ono, Y.
 1998
 30 4 p. 1164-1166
3 p.
 artikel
67 Development of a Macromolecular Prodrug of FK 506: III: In Vivo Disposition of FK 506-Dextran Conjugate Yoshimura, N
 1998
 30 4 p. 1029-1030
2 p.
 artikel
68 Development of a Macromolecular Prodrug of FK 506: II: In Vitro Study for FK 506-Dextran Conjugate Yura, H.
 1998
 30 4 p. 1031-1032
2 p.
 artikel
69 Development of Tolerance in a Chronic Rejection Model 1 1 Supported by a grant from the Deutsche Forschungsgemeinschaft (Tu-63/3-2). Tullius, S.G
 1998
 30 4 p. 1075-1076
2 p.
 artikel
70 Differences Between Compliers and Partial Compliers: A Multicenter Study Siegal, B
 1998
 30 4 p. 1310-1311
2 p.
 artikel
71 Differences in the Mode of Action of Cyclosporine and FK 506 1 1 Supported by Fujisawa GmBH. Hutchinson, I.V
 1998
 30 4 p. 959-960
2 p.
 artikel
72 Different Effects of Cyclosporine or Tacrolimus on Hepatocyte Acute Phase Proteins Krüger, B.
 1998
 30 4 p. 989-990
2 p.
 artikel
73 Differential Resistance of the Cellular Immune Responses and Immunoregulatory Properties of Human Cadaveric Donor Bone Marrow Cells to Immunosuppressive Drugs Commonly Used in Transplantation 1 1 Supported by NIH grant R01DK25243-15, Miami Veterans Administration Hospital Research Support, and a grant from Fujisawa Corp, USA. Mathew, J.M
 1998
 30 4 p. 1073-1074
2 p.
 artikel
74 Does Cyclosporin Promote the Secretion of Transforming Growth Factor-Beta 1 Following Pulmonary Transplantation? El-Gamel, A.
 1998
 30 4 p. 1525-1527
3 p.
 artikel
75 Does Initial Graft Function Influence the Outcome After Liver Transplantation? Mueller, A.R
 1998
 30 4 p. 1464-1465
2 p.
 artikel
76 Does Preexisting Elevated Pulmonary Vascular Resistance (Transpulmonary Gradient >15 mm Hg or >5 Wood) Predict Early and Long-Term Results After Orthotopic Heart Transplantation? Tenderich, G.
 1998
 30 4 p. 1130-1131
2 p.
 artikel
77 Donor Bone Marrow Infusion in Renal Transplantation Ciancio, G.
 1998
 30 4 p. 1365-1366
2 p.
 artikel
78 Donor-Recipient Sex Matching and Posttransplant Malignancies After Induction Therapy in Hepatic Transplantation Jonas, S
 1998
 30 4 p. 1490-1491
2 p.
 artikel
79 Donor-Specific Blood Transfusion Does Not Enhance the Effect of FTY720 in Rat Cardiac Allotransplantation Antoniou, E.A
 1998
 30 4 p. 1042-1043
2 p.
 artikel
80 Downregulation of Endothelin Expression in Allograft Coronary Arteries After Gene Therapy Targeting Cdk2 Kinase 1 1 Supported by a research grant for Immunology, Allergy and Organ Transplant, Ministry of Health and Welfare, grants from the Ono Medical Foundation, the Japan Medical Foundation, and the Japan Heart Foundation-Pfizer Pharmaceutical grant for research on coronary artery disease. Isobe, M
 1998
 30 4 p. 1007-1008
2 p.
 artikel
81 Early Posttransplantation Renal Hemodynamics in FK 506–Treated Kidney Recipients With or Without Prior Induction Therapy Rostaing, L
 1998
 30 4 p. 1279-1281
3 p.
 artikel
82 Early Treatment of Acute Rejection Prevents Chronic Rejection in a Rat Model of Allogenic Left Lung Transplantation Hirt, S.W
 1998
 30 4 p. 1005-1006
2 p.
 artikel
83 Early Use and Oral Absorption of Cyclosporine Neoral After Liver Transplantation Kattner, A
 1998
 30 4 p. 1422-1423
2 p.
 artikel
84 Effect of Allopurinol on the Metabolism of Azathioprine in Heart Transplant Patients 1 1 Sponsored by Cardiothoracic Transplant Research Funds. El-Gamel, A
 1998
 30 4 p. 1127-1129
3 p.
 artikel
85 Effect of Antirejection Therapy on HLA-DR Antigens and ICAM-1 Expression on Parenchymal Cells as Monitored by Fine Needle Aspiration Biopsy 1 1 Supported by grant 3067-2 from IGA MZ, Czech Republic. Lodererová, A
 1998
 30 4 p. 1176-1177
2 p.
 artikel
86 Effect of Breakfast on the Oral Bioavailability of Tacrolimus and Changes in Pharmacokinetics at Different Times Posttransplant in Renal Transplant Recipients Christiaans, M
 1998
 30 4 p. 1271-1273
3 p.
 artikel
87 Effect of CsA Versus FK 506 on Insulin Sensitivity and Insulin Response Using a Modeling Technique Steinmueller, T
 1998
 30 4 p. 1452-1453
2 p.
 artikel
88 Effect of Cyclosporine and Sirolimus on Interleukin-15–Driven Proliferation of OKT3-Preactivated Human Lymphocytes Degiannis, D.
 1998
 30 4 p. 948-949
2 p.
 artikel
89 Effect of Cyclosporine on Chronic Graft Vascular Disease in a Rat Cardiac Isograft Model Teranishi, K
 1998
 30 4 p. 1012-1013
2 p.
 artikel
90 Effect of Hemodynamics on Graft Rejection in the Heterotopic Heart Transplantation Model 1 1 Supported by Deutsche Forschungsgemeinschaft (DFG) La 910/2-1. Lange, V
 1998
 30 4 p. 1014-1016
3 p.
 artikel
91 Effect of Low Molecular Weight Heparin on Suppression of Chronic Graft Vascular Disease in a Rat Cardiac Allograft Model Teranishi, K
 1998
 30 4 p. 1009-1011
3 p.
 artikel
92 Effect of Mycophenolate Mofetil on Atherosclerosis in a Rabbit Model: Initial Histologic and Immunohistochemical Analyses 1 1 Supported by Roche, Inc (Nutley, NJ). Schreiber, T.C
 1998
 30 4 p. 961-962
2 p.
 artikel
93 Effect of Mycophenolate Mofetil on the In Vivo Infiltration of Lymphocytes in the Rat Remnant Kidney 1 1 Supported by DFG Grant He 1906/3-1. V.M., P.H., and A.S. are recipients of a DAAD stipend. Müller, V
 1998
 30 4 p. 982-
1 p.
 artikel
94 Effect of Race and Immunosuppression in Renal Transplantation: Three-Year Survival Results From a US Multicenter, Randomized Trial 1 1 This study was supported by a grant from Fujisawa USA, Inc, Deerfield, Ill. Neylan, J.F
 1998
 30 4 p. 1355-1358
4 p.
 artikel
95 Effect of Sandimmune Cyclosporine on Renal Blood Flow and Function in Heart Transplant Recipients 1 1 This study was supported by Novartis Pharmaceuticals UK Ltd. Chung, G
 1998
 30 4 p. 1147-1148
2 p.
 artikel
96 Effect of Tacrolimus on the Outcome of Renal Transplantation With Donor-Specific Blood Transfusion Miura, S
 1998
 30 4 p. 1212-1213
2 p.
 artikel
97 Effect of the Lazaroid U-74389G on Chemokine Gene Expression and Apoptosis in Renal Ischemia-Reperfusion Injury Shoskes, D.A.
 1998
 30 4 p. 974-975
2 p.
 artikel
98 Effects of Immunosuppression and Pretransplant Splenectomy in Newborn Cardiac Xenograft Survival Xu, H.
 1998
 30 4 p. 1084-
1 p.
 artikel
99 Effects of Tacrolimus and Cyclosporine on the Coronary Microcirculation After Heart Transplantation: A Prospective Study With Serial Intracoronary Flow Measurements Rieber, J
 1998
 30 4 p. 1098-1099
2 p.
 artikel
100 Elective Conversion of Patients From Cyclosporine to Tacrolimus for Hypertrichosis Fernando, O.N
 1998
 30 4 p. 1243-1244
2 p.
 artikel
101 Erratum 1998
 30 4 p. 1600-
1 p.
 artikel
102 Etiology of Early Renal Allograft Dysfunction After Live Donor Renal Transplantation Morrissey, P.E.
 1998
 30 4 p. 1320-
1 p.
 artikel
103 Evidence for a Type 2 Bias in the CD8+ T-Cell Response to Epstein-Barr Virus Following Heart Transplantation 1 1 Supported by NIH grant CA 63931 (M.J.C.). Cannon, M.J
 1998
 30 4 p. 1136-1139
4 p.
 artikel
104 Evidence for Microchimerism in Peripheral Blood, Bone Marrow, and Skin Following Donor Bone Marrow/Kidney–Pancreas Transplantation at 3 Years Burke, G.W
 1998
 30 4 p. 1555-
1 p.
 artikel
105 Experience With Azathioprine Withdrawal After Simultaneous Kidney–Pancreas Transplantation Stratta, R.J.
 1998
 30 4 p. 1353-1354
2 p.
 artikel
106 Experience With Neoral Cyclosporine Through the Oral Route in Liver Transplantation Bilbao, I.
 1998
 30 4 p. 1432-1434
3 p.
 artikel
107 Expression of Collagen by Renal Fibroblasts Treated With FK 506 In Vitro 1 1 Supported by a grant from Fujisawa and from the Italian Ministry of Health (Progetto Finalizzato H 129005). Ginevri, F
 1998
 30 4 p. 957-958
2 p.
 artikel
108 Factors Affecting the Pharmacokinetics of Tacrolimus in the First Year After Renal Transplantation Undre, N.A.
 1998
 30 4 p. 1261-1263
3 p.
 artikel
109 Failure of Ganciclovir Prophylaxis of Primary Cytomegalovirus Disease in Immunologic High-Risk Recipients Conti, D.J.
 1998
 30 4 p. 1314-1315
2 p.
 artikel
110 FK 506 and Mycophenolate Mofetil in Renal Transplant Recipients: Six-Month Results of a Multicenter, Randomized Dose Ranging Trial 1 1 This research was funded by Fujisawa USA, Inc, Deerfield, Ill. Mendez, R
 1998
 30 4 p. 1287-1289
3 p.
 artikel
111 FK 506 and Rapamycin in Combination Are Not Antagonistic but Produce Extended Small Bowel Graft Survival in the Mouse 1 1 Supported in part by the Research Center, Notre-Dame Hospital, by Fujisawa USA, and by Wyeth-Ayerst Research. Chen, H
 1998
 30 4 p. 1039-1041
3 p.
 artikel
112 FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation Preston, R
 1998
 30 4 p. 1214-1215
2 p.
 artikel
113 FK506 for Primary and Rescue Therapy Following Liver Transplantation Platz, K.P
 1998
 30 4 p. 1409-1410
2 p.
 artikel
114 FK506 Rescue Therapy in Lung Transplantation Wiebe, K
 1998
 30 4 p. 1508-1509
2 p.
 artikel
115 Future Challenges in Immunosuppression Land, W
 1998
 30 4 p. 1580-1584
5 p.
 artikel
116 Genetic Characteristics of Anti-Donor Immunoglobulin G Antibodies in the Hamster-to-Rat Model of Xenotransplantation Gochi, E.
 1998
 30 4 p. 1089-1090
2 p.
 artikel
117 Graft-Versus-Host Antibody Reactions in ABO Unmatched Renal Transplants Bertoni, E.
 1998
 30 4 p. 1333-1334
2 p.
 artikel
118 High Incidence and Clinical Course of Aggressive Skin Cancer in Heart Transplant Patients: A Single-Center Study Adamson, R
 1998
 30 4 p. 1124-1126
3 p.
 artikel
119 High Local Production of Nitric Oxide As a Possible Mechanism by Which Rapamycin Prevents Transplant Arteriosclerosis 1 1 Supported in part by a grant from the Thoracic Surgery Foundation for Research and Education and a Grant-in-Aid from the American Health Association. Pham, S.M
 1998
 30 4 p. 953-954
2 p.
 artikel
120 HMG-CoA Reductase Inhibitors Pravastatin and Simvastatin Inhibit Human B-Lymphocyte Activation Rudich, S.M
 1998
 30 4 p. 992-995
4 p.
 artikel
121 Humanized, Nonmitogenic OKT3 Antibody, huOKT3γ(Ala-Ala): Initial Clinical Experience Woodle, E.S.
 1998
 30 4 p. 1369-1370
2 p.
 artikel
122 Hyperacute Skin Allograft Rejection in Presensitized Rats Is Abrogated by Malononitrilamides Schorlemmer, H.U.
 1998
 30 4 p. 963-967
5 p.
 artikel
123 Hypercholesterolemia in Long-Term Survivors of Liver Transplantation: A Comparison Between Cyclosporine and FK 506 Charco, R
 1998
 30 4 p. 1489-
1 p.
 artikel
124 Immunoglobulin Class Switch of Posttransplant Panel Reactive Antibody and the Impact on Kidney Allograft Outcome Sumethkul, V.
 1998
 30 4 p. 1167-
1 p.
 artikel
125 Immunosuppression and Incidence of Opportunistic Pneumonias After Liver Transplantation Neumann, U.P.
 1998
 30 4 p. 1475-1476
2 p.
 artikel
126 Immunosuppression Using Tacrolimus, Mycophenolate, and Prednisone Following Orthotopic Liver Transplantation: A Single-Center Experience Rudich, S.M
 1998
 30 4 p. 1417-1418
2 p.
 artikel
127 Immunosuppression Withdrawal for Treatment of Severe Infections in Liver Transplantation Massarollo, P.C.B
 1998
 30 4 p. 1472-1474
3 p.
 artikel
128 Immunosuppressive Agents: Recent Developments in Molecular Action and Clinical Application Gerber, D.A
 1998
 30 4 p. 1573-1579
7 p.
 artikel
129 Immunosuppressive Effect of the Hydrophobic Extract of a Chinese Herb on Rat Lung Allograft Rejection 1 1 Supported in part by Grants RP930319 from the National University of Singapore and NMRC0223/1997 from the National Medical Research Council, Singapore. Yap, H.K
 1998
 30 4 p. 980-981
2 p.
 artikel
130 Impact of Immunosuppression in Liver Transplantation Across a Positive Crossmatch Lang, M.
 1998
 30 4 p. 1466-1467
2 p.
 artikel
131 Importance of Degree of Eosinophilia in Inflammatory Infiltrates Within Renal Allografts in the Response to Immunosuppressive Treatment Papadimitriou, J.C
 1998
 30 4 p. 1181-
1 p.
 artikel
132 Improved Immunosuppression With Combination Tacrolimus (FK506) and Mycophenolic Acid in Orthotopic Liver Transplantation Cai, T.H
 1998
 30 4 p. 1413-1414
2 p.
 artikel
133 Improvement of Nephrotoxicity, Hypertension, and Lipid Metabolism After Conversion of Kidney Transplant Recipients From Cyclosporine to Tacrolimus Friemann, S
 1998
 30 4 p. 1240-1242
3 p.
 artikel
134 Incidence of Acute Rejection in African-American Liver Transplant Recipients Maggard, M
 1998
 30 4 p. 1492-1494
3 p.
 artikel
135 Index 1998
 30 4 p. 1601-1607
7 p.
 artikel
136 Indications for Mycophenolate Mofetil Therapy in Hepatitis C-Patients Undergoing Liver Transplantation Platz, K.P
 1998
 30 4 p. 1468-1469
2 p.
 artikel
137 Influence of Early FK 506 Trough Levels on Glomerular Hemodynamics at 3 Months in Kidney Transplant Recipients Rostaing, L.
 1998
 30 4 p. 1282-1284
3 p.
 artikel
138 Influence of Hepatitis C Virus Infection on FK 506 Blood Levels in Renal Transplant Patients Manzanares, C
 1998
 30 4 p. 1264-1265
2 p.
 artikel
139 Influence of Immunosuppression in HTLV-1–Positive Renal Transplant Recipients Nakamura, N.
 1998
 30 4 p. 1324-1326
3 p.
 artikel
140 Influence of Immunosuppression on Patient Outcome After Liver Transplantation Mueller, A.R
 1998
 30 4 p. 1495-1496
2 p.
 artikel
141 Influence of Initial Antigen-Independent Events on Acute Allograft Rejection: Inhibition by a Soluble P-Selectin Ligand and Low-Dose Cyclosporine in Combination 1 1 Supported in part by USPHS grant 5RO1 DK 46190-24. Kusaka, M
 1998
 30 4 p. 1027-1028
2 p.
 artikel
142 Inhibition of Alloreactivity in the Popliteal Lymph Node Assay by Malononitrilamides Schorlemmer, H.U.
 1998
 30 4 p. 968-970
3 p.
 artikel
143 Inhibition of Intestinal Allograft Rejection by an Anti-CD8 Monoclonal Antibody Is Not Mediated by Depletion Alone He, G
 1998
 30 4 p. 1069-1070
2 p.
 artikel
144 Intrathymic Inoculation of Donor Bone Marrow at the Time of Transplantation Plus a Short Course of Tacrolimus Induce Long-Term Acceptance to Rat Lung Allografts 1 1 Supported in part by the Dalsemer Research Scholar Award from the American Lung Association and a Grant-in-Aid from the American Heart Association. Li, S
 1998
 30 4 p. 1065-1066
2 p.
 artikel
145 In Vitro Efficacy of Conjugates of Anti-CD45 Monoclonal Antibodies With Plant Toxin A-Chains 1 1 Supported by a grant from the Royal Society of London (RFFI 97-04-48686). Shumakov, V.I
 1998
 30 4 p. 971-973
3 p.
 artikel
146 In Vitro Generation of Tacrolimus Metabolites and Their Detection in Whole Blood Liu, W.T
 1998
 30 4 p. 1454-1456
3 p.
 artikel
147 In Vitro Study of BCX-34: A New Human T-Lymphocyte–Specific Purine Phosphorylase Inhibitor Iwata, H
 1998
 30 4 p. 983-986
4 p.
 artikel
148 Is Cyclosporine Toxic to the Transplanted Kidney With Acute Tubular Necrosis? Ritz, M
 1998
 30 4 p. 1204-
1 p.
 artikel
149 Is Liposomal Amphotericin B (Ambisome) an Effective Prophylaxis of Mycotic Infections After Liver Transplantation? Braun, F
 1998
 30 4 p. 1481-1483
3 p.
 artikel
150 Is Long-Term Chronic Immunosuppression Therapy Detrimental in Hepatitis C Virus–Positive Renal Transplant Patients? Rostaing, L
 1998
 30 4 p. 1312-1313
2 p.
 artikel
151 Isolated Lung Transplantation for End-Stage Pulmonary Disease Venuta, F
 1998
 30 4 p. 1521-1522
2 p.
 artikel
152 Is TGF-β a Profibrotic Cytokine in Human Renal Transplants? Nicholson, M.L.
 1998
 30 4 p. 952-
1 p.
 artikel
153 Late Acute Rejection Episodes After Vascularized Pancreas Transplantation Stratta, R.J.
 1998
 30 4 p. 1560-1561
2 p.
 artikel
154 Late Acute Rejection is More Prevalent Among African-American Renal Allograft Recipients and is Frequently Associated With Allograft Loss Vasquez, E.M
 1998
 30 4 p. 1173-1175
3 p.
 artikel
155 Limited Sampling Strategy for the Determination of Mycophenolic Acid Area Under the Curve in Pediatric Kidney Recipients 1 1 Additional contributing investigators from the German Study Group (in alphabetical order of the centers): R. Böswald, H. Ruder (Erlangen), M. Schröder, J. Dippel (Frankfurt), A. Staskewitz, G. Kirste (Freiburg), M. Holder, H. Leichter (Stuttgart). Schütz, E
 1998
 30 4 p. 1182-1184
3 p.
 artikel
156 Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients 1 1 This research was supported by Fujisawa, GmbH. Claesson, K
 1998
 30 4 p. 1292-1294
3 p.
 artikel
157 Liposomal Tacrolimus: Drug Migration Within Blood Compartments 1 1 Supported by a grant from Fujisawa, Canada. McAlister, V.C
 1998
 30 4 p. 1000-1001
2 p.
 artikel
158 Liver Transplantation Under Tacrolimus In Infants, Children, Adults, and Seniors: Long-Term Results, Survival, and Adverse Events in 1000 Consecutive Patients Jain, A
 1998
 30 4 p. 1403-1404
2 p.
 artikel
159 Living Related Liver Transplantation for Patients With Renal Failure Fuchinoue, S
 1998
 30 4 p. 1479-1480
2 p.
 artikel
160 Long-Term Comparison of Tacrolimus and Cyclosporine-Based Immunosuppression in Kidney Recipients With Grafts From Non-Heart-Beating Cadaver Donor Kinukawa, T.
 1998
 30 4 p. 1227-1229
3 p.
 artikel
161 Long-Term Comparison of Tacrolimus Versus Cyclosporine in Liver Transplantation 1 1 This study was supported in part by Fujisawa USA, Inc, Deerfield, Ill. Wiesner, R.H
 1998
 30 4 p. 1399-1400
2 p.
 artikel
162 Long-Term Kidney and Pancreas Function With Tacrolimus Immunosuppression Following Simultaneous Kidney and Pancreas Transplantation Peddi, V.R
 1998
 30 4 p. 1541-1543
3 p.
 artikel
163 Long-Term Outcomes in Simultaneous Kidney–Pancreas Transplant Recipients Stratta, R.J.
 1998
 30 4 p. 1564-1565
2 p.
 artikel
164 Long-Term Outcome With the Use of OKT3 Induction Therapy in Heart Transplant Patients: A Single-Center Experience Adamson, R.
 1998
 30 4 p. 1107-1109
3 p.
 artikel
165 Long-Term Results of Living Kidney Transplantation Under Tacrolimus Immunosuppression: A Single-Center Experience Tanabe, K
 1998
 30 4 p. 1224-1226
3 p.
 artikel
166 Long-Term Steroid Side Effects in Renal Transplantation Need a Safe Steroid Withdrawal: A Single-Center Experience Bertoni, E
 1998
 30 4 p. 1303-1304
2 p.
 artikel
167 Long-Term Treatment With CsA Decreases INF-γ mRNA and Increases Pre-Pro-ET-1 mRNA in Rat Kidneys Murer, L.
 1998
 30 4 p. 950-951
2 p.
 artikel
168 Low-Dose OKT3 Treatment for Rejection/Induction in Kidney and Kidney–Pancreas Transplantation Desai, D.M
 1998
 30 4 p. 1552-1554
3 p.
 artikel
169 Lower Incidence of Liver Graft Rejection in Patients on Diltiazem Plus Cyclosporine Therapy Mies, S
 1998
 30 4 p. 1437-1438
2 p.
 artikel
170 Low Incidence of Acute Rejection in Kidney Grafts Treated With Initial Quadruple Therapy: A Retrospective Analysis Comparing Two ATGs Civati, G
 1998
 30 4 p. 1343-1345
3 p.
 artikel
171 Low Rejection Rate After Hepatic Transplantation Achieved With a Cyclosporine-Based Quadruple Immunosuppressive Regimen Ott, R
 1998
 30 4 p. 1427-1429
3 p.
 artikel
172 Lymphoproliferative Disease After Liver Transplantation: Primary Biliary Localization Navarro, F.
 1998
 30 4 p. 1486-1488
3 p.
 artikel
173 Malononitrilamides Reduce IgM and IgG Xenoantibodies and Prolong Skin Xenograft Survival in a Mouse-to Rat Model Schorlemmer, H.U.
 1998
 30 4 p. 976-979
4 p.
 artikel
174 Medium-Term Outcome of Tacrolimus Immunosuppression Following Rejection or Graft Dysfunction in Heart Transplant Patients Marcus, N.
 1998
 30 4 p. 1134-1135
2 p.
 artikel
175 Meta-Analysis of FK 506 and Mycophenolate Mofetil Refractory Rejection Trials in Renal Transplantation Woodle, E.S
 1998
 30 4 p. 1297-1298
2 p.
 artikel
176 Metabolic Findings After Liver Transplantation Within a Randomised Trial With or Without Steroids Tisone, G
 1998
 30 4 p. 1447-1448
2 p.
 artikel
177 Methylprednisolone in Bilayer Liposomes Prolongs Cardiac and Renal Allograft Survival, Inhibits Macrophage Activation, and Selectively Modifies Antigen Presentation and T-Helper Cell Function in Rat Recipients Binder, J
 1998
 30 4 p. 1051-
1 p.
 artikel
178 Mycophenolate Mofetil in Lung Transplantation Zuckermann, A
 1998
 30 4 p. 1514-1516
3 p.
 artikel
179 Mycophenolate Mofetil’s Effect on Accelerated Heart Allograft Rejection and Rejection Markers in the Rat 1 1 Supported by Roche Bioscience, USA, and by the Research Center, CHUM-Pavilion Notre-Dame. Chen, H
 1998
 30 4 p. 1049-1050
2 p.
 artikel
180 Mycophenolate Mofetil Versus Azathioprine in Simultaneous Pancreas–Kidney Transplant Recipients on Cyclosporine Fabrega, A.J.
 1998
 30 4 p. 1562-1563
2 p.
 artikel
181 National Transplantation Pregnancy Registry: Outcomes of Pregnancies in Lung Recipients 1 1 Supported by grants from Sandoz Transplant, a Division of Novartis Pharmaceuticals Corp, Fujisawa USA, Inc, and Roche Laboratories Inc. Armenti, V.T
 1998
 30 4 p. 1528-1530
3 p.
 artikel
182 Natural History and the Clinical Importance of Early and Late Grade 2 Cellular Rejection Following Cardiac Transplantation 1 1 Supported by Wythenshawe Transplant research funds. El-Gamel, A
 1998
 30 4 p. 1143-1146
4 p.
 artikel
183 Neoral Conversion in Stable Thoracic Transplant Patients Leads to Dose Reduction 1 1 This research has been supported in part by an unrestricted grant by Novartis Pharmaceutical Corporation, East Hanover, New Jersey. Zaldonis, D.B
 1998
 30 4 p. 1158-1159
2 p.
 artikel
184 Novel Concept for Easy Quantification of Posttransplant Immunocompetence Nagashima, N.
 1998
 30 4 p. 1168-1169
2 p.
 artikel
185 One Hundred Children Treated With Tacrolimus After Primary Orthotopic Liver Transplantation McDiarmid, S.
 1998
 30 4 p. 1397-1398
2 p.
 artikel
186 Optimal Time Points for the Prediction of the Area-Under-The-Curve in Liver Transplant Patients Receiving Tacrolimus Cantarovich, M
 1998
 30 4 p. 1460-1461
2 p.
 artikel
187 Oral Delivery of Low Molecular Weight Heparin in Rat Cardiac Allografts Teranishi, K
 1998
 30 4 p. 996-997
2 p.
 artikel
188 Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant “CMV at Risk” Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid) 1 1 This work has been presented in part at the International Congress on Immunosuppression, Orlando, Florida, December 12, 1997. Ahsan, N
 1998
 30 4 p. 1383-1385
3 p.
 artikel
189 Outcome After Steroid Withdrawal in Renal Transplant Patients Receiving Tacrolimus-Based Immunosuppression Shapiro, R
 1998
 30 4 p. 1375-1377
3 p.
 artikel
190 Pharmaco-Economic Study of FK 506 (Prograf) and Cyclosporine A Neoral in Cadaveric Renal Transplantation Morris-Stiff, G
 1998
 30 4 p. 1285-1286
2 p.
 artikel
191 Pharmacokinetics of FK 506 and Mycophenolic Acid After the Administration of a FK 506–Based Regimen in Combination With Mycophenolate Mofetil in Kidney Transplantation Undre, N.A
 1998
 30 4 p. 1299-1302
4 p.
 artikel
192 Pharmacokinetics of Tacrolimus (FK506) in Primary Orthotopic Heart Transplant Patients Undre, N.A
 1998
 30 4 p. 1112-1115
4 p.
 artikel
193 Placebo-Controlled Study of a Humanized Anti-TAC Monoclonal Antibody in Dual Therapy for Prevention of Acute Rejection After Renal Transplantation 1 1 The study was supported by Hoffmann La Roche. Charpentier, B
 1998
 30 4 p. 1331-1332
2 p.
 artikel
194 Polyclonal Antilymphocyte Sera Induce Immune Activation in Human Renal Allograft Recipients Book, B.
 1998
 30 4 p. 1348-1350
3 p.
 artikel
195 Posttransplant Lymphoproliferative Disorders in Cardiac Transplant Patients Fatio, R
 1998
 30 4 p. 1118-1120
3 p.
 artikel
196 Pravastatin and Cyclosporine Inhibit Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cell Mitogenesis: An Investigation of Mechanisms 1 1 Supported in part by a grant from Bristol-Myers Squibb. Katznelson, S
 1998
 30 4 p. 998-999
2 p.
 artikel
197 Predicting Factors for Long-Term Results of OKT3 Therapy in Steroid-Resistant Acute Rejection Following Cadaveric Renal Transplantation Rostaing, L.
 1998
 30 4 p. 1170-1172
3 p.
 artikel
198 Prediction of Early Graft Function in Renal Transplantation Using a Computer Neural Network Shoskes, D.A.
 1998
 30 4 p. 1316-1317
2 p.
 artikel
199 Preoperative Induction Therapy With Oral Cyclosporine for Recipients of Living-Related Renal Transplants Rudich, S.M
 1998
 30 4 p. 1339-1342
4 p.
 artikel
200 Preoperative Induction With Tacrolimus Does Not Have a Detrimental Effect on Primary Graft Function in Adult Cadaveric Renal Transplantation Morris-Stiff, G
 1998
 30 4 p. 1230-1231
2 p.
 artikel
201 Prevalence of Malignancies After Lung Transplantation Spiekerkoetter, E.
 1998
 30 4 p. 1523-1524
2 p.
 artikel
202 Prevention of Experimentally Induced Autoimmune Type I Diabetes in Rats by the New Immunosuppressive Reagent FTY720 Suzuki, K.
 1998
 30 4 p. 1044-1045
2 p.
 artikel
203 Prevention of Recurrence of Autoimmune Diabetes Type I in Rats Following Pancreaticoduodenal Transplantation Suzuki, K.
 1998
 30 4 p. 1071-1072
2 p.
 artikel
204 Pre- Versus Intraoperative Application of Glucocorticosteroids as Inductive Therapy in Renal Transplantation Fricke, L
 1998
 30 4 p. 1346-1347
2 p.
 artikel
205 Primary Low-Dose Tacrolimus Immunosuppressive Prophylaxis for High-Risk Kidney Transplant Recipients Braun, F
 1998
 30 4 p. 1221-1223
3 p.
 artikel
206 Primary Therapy With OKT3 for Biopsy-Proven Acute Renal Allograft Rejection Kamath, S
 1998
 30 4 p. 1178-1180
3 p.
 artikel
207 Prolonged Rat Cardiac Allograft Survival Using Adenoviral Vector Containing the CTLA4Ig Gene 1 1 Supported by grants from the Minister of Health and Welfare (9KO-2), a grant for science research, and the Minister of Education (grants 07457265, 09470273, and 09307025). Kita, Y
 1998
 30 4 p. 1079-1080
2 p.
 artikel
208 Prolonged Survival of Recipient Rats With Fas-Ligand-Transfected Liver Allografts by Using HVJ-Liposome 1 1 Supported by research grants from the Ministry of Health and Welfare of Japan (9KO-2) and the Ministry of Education of Japan (WO.07457265, 09671271, and 09307025). Li, X.-K
 1998
 30 4 p. 943-
1 p.
 artikel
209 Prospective Randomized Study Comparing FK 506 (Prograf) and Cyclosporine A (Neoral) as Primary Immunosuppression in Cadaveric Renal Transplants at a Single Institution: Interim Report of the First 80 Cases Morris-Stiff, G
 1998
 30 4 p. 1295-1296
2 p.
 artikel
210 Protocol Liver Biopsies: The Case in Favour Neuberger, J
 1998
 30 4 p. 1497-1499
3 p.
 artikel
211 Randomized Trial to Evaluate the Use of Increasing the Steroid Dose During Conversion From Cyclosporine to Azathioprine Roodnat, J.I
 1998
 30 4 p. 1199-1200
2 p.
 artikel
212 Rapamycin’s Effect on Vasomotion in the Rat 1 1 Supported in part by the Research Center, Notre-Dame Hospital and by Wyeth-Ayerst Research (Rouses Point, NY). Milliard, S
 1998
 30 4 p. 1036-1038
3 p.
 artikel
213 Rapid Trabecular Bone Loss After Cardiac Transplantation Using FK506 (Tacrolimus)-Based Immunosuppression 1 1 This investigation was supported by a Grant awarded by the Ernst und Berta Grimmke Research Foundation. Stempfle, H.U
 1998
 30 4 p. 1132-1133
2 p.
 artikel
214 Reduced Acute Rejection and Side Effects With Neoral in Liver Transplantation Tisone, G
 1998
 30 4 p. 1430-1431
2 p.
 artikel
215 Reduced Severity of Acute Rejection in Hepatitis C Virus Positive Renal Allograft Recipients: Are Milder Immunosuppressive Regimens Advisable? Pascual, J.
 1998
 30 4 p. 1329-1330
2 p.
 artikel
216 Relation of Mycophenolic Acid Trough Levels and Adverse Events in Kidney Allograft Recipients 1 1 Supported by grant C951472 from the Dutch Kidney Foundation. Smak Gregoor, P.J.H
 1998
 30 4 p. 1192-1193
2 p.
 artikel
217 Renal Allograft Survival Can Be Predicted by Histomorphometric Assessment of Extracellular Matrix in 6-Month Protocol Biopsies 1 1 Supported by a grant from the Trent Regional Health Authority. The image analysis program NIH-image was written by Wayne Rasband @ http://rsb.infor.nihgov/nih-image/. Nicholson, M.L
 1998
 30 4 p. 1305-1306
2 p.
 artikel
218 Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus) Van Buren, D
 1998
 30 4 p. 1401-1402
2 p.
 artikel
219 Rescue FK506 Therapy for Acute Rejection and Early Chronic Rejection After Liver Transplantation: Report of 14 Cases Taibi, A
 1998
 30 4 p. 1411-1412
2 p.
 artikel
220 Retransplantation for Recurrent Hepatitis C Following Tacrolimus or Cyclosporine Immunosuppression Ghobrial, R.M
 1998
 30 4 p. 1470-1471
2 p.
 artikel
221 Reversal of Delayed Hyperacute Renal Allograft Rejection With a Tacrolimus-Based Therapeutic Regimen Loss Jr., G.E.
 1998
 30 4 p. 1249-1250
2 p.
 artikel
222 Risk and Benefit of Antibody Induction Therapy in Combination With Tacrolimus Immunosuppression After Liver Transplantation Klupp, J.
 1998
 30 4 p. 1443-1444
2 p.
 artikel
223 Risk of Acute Cellular Rejection After Azathioprine Withdrawal in Stable Renal Allograft Recipients on Cyclosporine, Azathioprine, and Prednisone Fabrega, A.J
 1998
 30 4 p. 1335-1336
2 p.
 artikel
224 Risks and Benefits of Withdrawing Cyclosporine From the Long-Term Immunosuppression Regimen of Heart and Heart-Lung Transplant Recipients Walker, S.
 1998
 30 4 p. 1149-1151
3 p.
 artikel
225 Role of Acute Rejection in Chronic Rejection Vanrenterghem, Y
 1998
 30 4 p. 1210-1211
2 p.
 artikel
226 Selective Cellcept Therapy in High-Risk Renal Transplant Recipients Isenberg, A.
 1998
 30 4 p. 1188-1189
2 p.
 artikel
227 Sequential Pancreas After Kidney Transplantation: Is Anti-Lymphocyte Induction Therapy Needed? Stratta, R.J
 1998
 30 4 p. 1549-1551
3 p.
 artikel
228 Significance of Serial Biopsies After Renal Allograft in Children Murer, L
 1998
 30 4 p. 1321-1323
3 p.
 artikel
229 Small Bowel Transplantation Alone or With the Liver in Children: Changes by Using FK506 Goulet, O.
 1998
 30 4 p. 1569-1570
2 p.
 artikel
230 Specificity of Therapeutic Drug Monitoring of Tacrolimus in Kidney Transplant Patients Sato, S.
 1998
 30 4 p. 1274-1275
2 p.
 artikel
231 Squirrel Monkeys Hyperacutely Reject Porcine Musculocutaneous Flaps Despite a Lack of Naturally Occurring Xenoantibodies 1 1 This study was funded, in part, by a gift from Fugisawa USA, Inc. Gregory, C.R
 1998
 30 4 p. 1082-1083
2 p.
 artikel
232 Stabilization of Bone Mass After Renal Transplant With Preemptive Care Hurst, G.
 1998
 30 4 p. 1327-1328
2 p.
 artikel
233 Steroid Withdrawal in Renal Transplant Recipients: Pro Point of View Hricik, D.E.
 1998
 30 4 p. 1380-1382
3 p.
 artikel
234 Successful Prednisone Withdrawal After Living-Related Liver Transplantation Abe, M.
 1998
 30 4 p. 1441-1442
2 p.
 artikel
235 Successful Therapy of Chronic Renal Allograft Failure by Enhanced Immunosuppression Kliem, V
 1998
 30 4 p. 1207-1209
3 p.
 artikel
236 Successful Use of Tacrolimus for Initial Rejection Episodes After Liver Transplantation Millis, J.M.
 1998
 30 4 p. 1407-1408
2 p.
 artikel
237 Superior Efficacy of Oral Ganciclovir Over Oral Acyclovir for Cytomegalovirus Prophylaxis in Kidney–Pancreas and Pancreas Alone Recipients Somerville, T
 1998
 30 4 p. 1546-1548
3 p.
 artikel
238 Survival of Heart Transplant Recipients With Cyclosporine-Induced Renal Insufficiency van Gelder, T.
 1998
 30 4 p. 1122-1123
2 p.
 artikel
239 Tacrolimus and Mycophenolate Mofetil in Clinical Liver Transplantation: Experience With a Steroid-Sparing Concept Ringe, B
 1998
 30 4 p. 1415-1416
2 p.
 artikel
240 Tacrolimus as a Primary Immunosuppressive Therapy in Cadaveric Renal Transplantation: Five Years’ Experience at a Single Center Schneeberger, H
 1998
 30 4 p. 1598-1599
2 p.
 artikel
241 Tacrolimus Dosing Requirements in Diabetic and Nondiabetic Patients Calculated From Pretransplantation Data van Duijnhoven, E
 1998
 30 4 p. 1266-1267
2 p.
 artikel
242 Tacrolimus Enhances the Immunosuppressive Effect of Cyclophosphamide But Not That of Leflunomide or Mycophenolate mofetil in a Model of Discordant Liver Xenotransplantation 1 1 Aided by Project Grant No. DK29961 from the National Institutes of Health, Bethesda, Maryland. Miki, T
 1998
 30 4 p. 1091-1092
2 p.
 artikel
243 Tacrolimus (FK506)-Based Dual Versus Triple Therapy Following Liver Transplantation 1 1 This study was sponsored by Fujisawa GmbH, Munich. Samuel, D
 1998
 30 4 p. 1394-1396
3 p.
 artikel
244 Tacrolimus (FK 506) in Kidney Transplantation: Three-Year Survival Results of the US Multicenter, Randomized, Comparative Trial 1 1 Supported by a grant from Fujisawa USA, Inc, Deerfield, Illinois. Jensik, S.C
 1998
 30 4 p. 1216-1218
3 p.
 artikel
245 Tacrolimus for Rescue of Refractory Renal Allograft Rejection 1 1 This work was supported in part by a grant from Fujisawa USA, Inc (D.S.). Jordan, M.L
 1998
 30 4 p. 1257-1260
4 p.
 artikel
246 Tacrolimus for Steroid- and OKT3-Resistant Rejection in Kidney Recipients Kliem, V
 1998
 30 4 p. 1251-1253
3 p.
 artikel
247 Tacrolimus/Mycophenolate Mofetil/Steroid-Based Immunosuppression After Pancreas-Kidney Transplantation With Single Shot Antithymocyte Globulin Schulz, T
 1998
 30 4 p. 1533-1535
3 p.
 artikel
248 Tacrolimus/Mycophenolate Provides Superior Immunosuppression Relative to Neoral/Mycophenolate in Synchronous Pancreas-Kidney Transplantation Bruce, D.S
 1998
 30 4 p. 1538-1540
3 p.
 artikel
249 Tacrolimus Rescue Therapy in Late Rejection After Renal Transplantation: Outcome After 18 Months Budde, K.
 1998
 30 4 p. 1238-1239
2 p.
 artikel
250 Tacrolimus Therapy for ABO-Incompatible Kidney Transplantation Takahashi, K
 1998
 30 4 p. 1219-1220
2 p.
 artikel
251 Tacrolimus Therapy for Refractory Acute Renal Allograft Rejection: A 4-Year Experience With an Aggressive Approach Turner, C.D.
 1998
 30 4 p. 1234-1235
2 p.
 artikel
252 T Cells Infiltrating Coronary Arteries of Cardiac Allografts With Chronic Rejection Contain Clonally Expanded T Lymphocytes 1 1 Supported in part by grants P01 AI40160 and T32 AI07101 from the National Institute of Allergy and Infectious Diseases. Slachta, C.A
 1998
 30 4 p. 1002-1004
3 p.
 artikel
253 TGF-β: A Link Between Immunosuppression, Nephrotoxicity, and CsA Khanna, A.K
 1998
 30 4 p. 944-945
2 p.
 artikel
254 The Cost of Rejection in Liver Allograft Recipients Martin, J.E
 1998
 30 4 p. 1500-1501
2 p.
 artikel
255 The Effect of Breakfast on the Oral Bioavailability of Tacrolimus in Diabetic and Nondiabetic Patients Before Transplantation van Duijnhoven, E
 1998
 30 4 p. 1268-1270
3 p.
 artikel
256 The “Infectious” Tolerance Pathway in Organ Allograft Recipients 1 1 This work was supported by USPHS grant AI23847 and NATO grant (CRG.951353). Kupiec-Weglinski, J.W
 1998
 30 4 p. 1595-1597
3 p.
 artikel
257 The Necessity for Steroid Induction or Long-Term Maintenance After Liver Transplantation: The Argument Against McDiarmid, S.
 1998
 30 4 p. 1449-1451
3 p.
 artikel
258 Therapeutic Drug Monitoring of Mycophenolic Acid: Comparison of HPLC and Immunoassay Reveals New MPA Metabolites Schütz, E
 1998
 30 4 p. 1185-1187
3 p.
 artikel
259 Therapy of Hyperlipidemia With Lovastatin in Kidney Transplant Patients on Cyclosporine A Immunosuppression: Three-Year Experience Kandus, A
 1998
 30 4 p. 1307-1309
3 p.
 artikel
260 Three-Year Follow-Up of Low Dose Tacrolimus Oral Therapy After Liver Transplantation: A Single-Centre Experience Rossi, G.
 1998
 30 4 p. 1391-1393
3 p.
 artikel
261 Treatment of Cyclosporine-Related Adverse Effects by Conversion to Tacrolimus After Liver Transplantation: Long-Term Results Pratschke, J
 1998
 30 4 p. 1419-1421
3 p.
 artikel
262 Tumor Recurrence in Liver Grafts: Two Animal Models Schotman, S.N
 1998
 30 4 p. 1052-1053
2 p.
 artikel
263 Unusual Course of T-Cell Lymphoproliferative Disorder in a Cardiac Transplant Patient Fatio, R.
 1998
 30 4 p. 1121-
1 p.
 artikel
264 Use of Intravenous Immunoglobulin in Sensitized LVAD Recipients Dowling, R.D.
 1998
 30 4 p. 1110-1111
2 p.
 artikel
265 Use of Intravenous Tacrolimus to Reverse Vascular Rejection in Kidney and Simultaneous Kidney-Pancreas Transplantation Ciancio, G
 1998
 30 4 p. 1536-1537
2 p.
 artikel
266 Use of Mycophenolate Mofetil in Patients With Chronic Cyclosporine Nephrotoxicity Wombolt, D.G
 1998
 30 4 p. 1194-
1 p.
 artikel
267 Use of Tacrolimus and Mycophenolate Mofetil For Pancreas–Kidney Transplantation With or Without OKT3 Induction Burke, G.W
 1998
 30 4 p. 1544-1545
2 p.
 artikel
268 Use of Tacrolimus as the Primary Immunosuppression After Renal Transplant in Native Americans and Hispanics Eghtesad, B.
 1998
 30 4 p. 1232-1233
2 p.
 artikel
                             268 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland